Brain Cancer Biomarker Enables Targeted Treatment

News   Oct 17, 2017 | Original Story from the Icahn School of Medicine at Mount Sinai

 
Biomarker for Glioblastoma Predicts Clinical Course and Sensitivity to Treatment
 
 
 

RELATED ARTICLES

Lab Innovations returns to the NEC, Bimingham , UK

News

Save the date for the UK’s only lab-dedicated exhibition showcase!

READ MORE

Antibody Drug-Conjugate to Target Treatment-Resistant Childhood Leukemia

News

Researchers have discovered that a protein (5T4) found on the surface of cells contributes to chemotherapy resistance in the most common type of childhood leukaemia. Using a novel approach, early testing shows that targeting the protein with an antibody drug conjugate (ADC) could hold promise in improving treatment.

READ MORE

Immune Cells Hold Promise In Slowing ALS

News

Recent research showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive and fatal disease.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE